Cargando…
International recommendations on the diagnosis and treatment of acquired hemophilia A
Acquired hemophilia A (AHA), a rare bleeding disorder caused by neutralizing autoantibodies against coagulation factor VIII (FVIII), occurs in both men and women without a previous history of bleeding. Patients typically present with an isolated prolonged activated partial thromboplastin time due to...
Autores principales: | Tiede, Andreas, Collins, Peter, Knoebl, Paul, Teitel, Jerome, Kessler, Craig, Shima, Midori, Di Minno, Giovanni, d’Oiron, Roseline, Salaj, Peter, Jiménez-Yuste, Victor, Huth-Kühne, Angela, Giangrande, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327664/ https://www.ncbi.nlm.nih.gov/pubmed/32381574 http://dx.doi.org/10.3324/haematol.2019.230771 |
Ejemplares similares
-
Consensus recommendations for the diagnosis and treatment of acquired hemophilia A
por: Collins, Peter, et al.
Publicado: (2010) -
A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH
por: van Galen, Karin P. M., et al.
Publicado: (2021) -
The International Prospective Glanzmann Thrombasthenia Registry: Pediatric Treatment and Outcomes
por: Zotz, Rainer B., et al.
Publicado: (2019) -
The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status
por: Poon, Man-Chiu, et al.
Publicado: (2023) -
International consensus recommendations on the management of people with haemophilia B
por: Hart, Daniel P., et al.
Publicado: (2022)